Ads
related to: bristol-myers squibbscbn.org has been visited by 10K+ users in the past month
Search results
Why Mindy Kaling Is Advocating for a Health Condition She Doesn't Have
SheKnows· 2 days agoMindy Kaling is no stranger to advocating for herself. Before she created hit shows like The Mindy...
Florida Man Makes Medical Device – A Survey of MedTech in the Sunshine State | JD Supra
JD Supra· 7 days agoFlorida is more than just the home of alligators and presidential candidates. The state was recently ranked as the fourth largest “medical device...
1st-Quarter Earnings Season Results, Expectations for 2024
Guru Focus· 1 day agoFirst-quarter earnings season has become one of the important market supporting factors during...
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Benzinga· 6 days agoThursday, Verastem Oncology VSTM announced the initial interim safety and efficacy results from the...
Princeton Prepares for Pride Month Events: Flag-Raising, Picnic, Dance, and More
Princeton Town Topics· 2 days agoLaunching its celebration of diversity, inclusion, and community, Princeton will be hosting a flag-raising, a Pride Picnic, and a Pride Dance Party this Friday on the eve of Pride Month. Following ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 days agoDiabetic Kidney Disease Market Size to Worth USD 5.32 Bn By 2031 PR Newswire BURLINGAME, Calif., May 28, 2024 BURLINGAME, Calif., May 28, 2024 /PRNewswire/ -- According to Coherent Market Insights, the global diabetic kidney disease market size
Denovo Biopharma LLC to Present Positive Phase 2b ENLIGHTEN Trial Data for DGM4 Biomarker-Guided...
WJTV Jackson· 2 days agoThe oral presentation will be discussed in a session entitled "Use of Biomarkers to Identify Treatments for Psychiatric Patients: The Right Medicine for the Right Patient at the Right Time" ...
BostonGene Immune Profiling Platform Shows Promise in Predicting Cancer Immunotherapy Benefit
GenomeWeb News· 6 days agoBostonGene wants to further validate a blood-based, machine learning-powered immune profiling platform that has shown potential in classifying cancer patients' immune phenotypes and monitoring ...